Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03010163 · ClinicalTrials.gov registry record · NA
Taxi STEP (Social Networks, Technology, and Exercise Through Pedometers)
A NA study of Physical Conditioning, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 290
- Enrollment target
- 1
- Study location
NCT03010163: Active NA study of Physical Conditioning, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03010163 is a NA study of Physical Conditioning that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 290 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03010163, a NA study of Physical Conditioning, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is divided into four groups. Group 1 includes Health Fairs implemented at NYC taxi garage bases and airport taxi holding lots and pedometers. Group 2 includes Health Fairs, pedometers and text messaging to facilitate walking and living a healthier lifestyle. Group 3 includes Health Fairs, pedometers and social network support. Group 4 includes Health Fairs, pedometers, text messaging and social network support.
Primary Outcome
Increase average step counts per day
Conditions Studied
Interventions
- OTHER Health Fair
- OTHER Pedometer
- OTHER Text Messaging
- OTHER Social Network Support
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2016-12 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT03010163 still lists
NCT03010163 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Physical Conditioning appearing as the primary indexed condition, and to 4 interventions - of which Health Fair is the first listed.
NCT03010163 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03010163 about?
NCT03010163 is a clinical study titled "Taxi STEP (Social Networks, Technology, and Exercise Through Pedometers)". This study is divided into four groups. Group 1 includes Health Fairs implemented at NYC taxi garage bases and airport taxi holding lots and pedometers. Group 2 includes Health Fairs, pedometers and text messaging to facilitate walking and living a healthier lifestyle. Group 3 includes Health Fairs,...
What is the current status of trial NCT03010163?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 290 participants. The study started on 2016-12. Estimated completion is 2026-06.
What conditions does trial NCT03010163 study?
This clinical trial studies the following conditions: Physical Conditioning.
What interventions are being tested in trial NCT03010163?
The interventions under investigation include: Health Fair (OTHER), Pedometer (OTHER), Text Messaging (OTHER), Social Network Support (OTHER).
Who is sponsoring clinical trial NCT03010163?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03010163 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03010163's enrollment target sits among peer trials
290 375th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia